Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Office of Legislative Affairs

This article was originally published in The Tan Sheet

Executive Summary

Proposed reorganization, announced in the May 9 Federal Register, would separate OLA into two staff offices that would serve as the agency's focal point with Congress, HHS, PHS and other agencies on legislative issues. Congressional Affairs Staff I would handle legislative issues that involve the Center for Food Safety and Applied Nutrition, the National Center for Toxicological Research and the veterinary drugs center; Congressional Affairs Staff II would serve the same legislative purpose on issues that pertain to the Center for Drug Evaluation & Research as well as the biologics and device centers

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel